标题
The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitors
作者
关键词
-
出版物
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 84, Issue 8, Pages 1686-1695
出版商
Wiley
发表日期
2018-04-18
DOI
10.1111/bcp.13611
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure
- (2018) John J.V. McMurray et al. JACC-Heart Failure
- Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk
- (2018) Benjamin M. Scirica et al. JAMA Cardiology
- Cardiovascular Safety of Dipeptidyl-Peptidase IV Inhibitors: A Meta-Analysis of Placebo-Controlled Randomized Trials
- (2016) Islam Y. Elgendy et al. American Journal of Cardiovascular Drugs
- In vivo and in vitro degradation of peptide YY3–36 to inactive peptide YY3–34 in humans
- (2016) Signe Toräng et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs
- (2016) Sengwee Toh et al. ANNALS OF INTERNAL MEDICINE
- Clinical Update: Cardiovascular Disease in Diabetes Mellitus
- (2016) Cecilia C. Low Wang et al. CIRCULATION
- Age and Human Regenerative Capacity Impact of Cardiovascular Risk FactorsNovelty and Significance
- (2016) Ibhar Al Mheid et al. CIRCULATION RESEARCH
- Roles of the Gut in Glucose Homeostasis
- (2016) Jens Juul Holst et al. DIABETES CARE
- Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure
- (2016) Shuo-Ming Ou et al. HEART
- Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials
- (2016) J. Kongwatcharapong et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effects of Dipeptidyl Peptidase 4 Inhibitors and Sodium-Glucose Linked coTransporter-2 Inhibitors on cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis
- (2016) Gianluigi Savarese et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes
- (2016) Gian Paolo Fadini et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of dipeptidyl peptidase-4 inhibitors on blood pressure in patients with type 2 diabetes
- (2016) Xiaodan Zhang et al. JOURNAL OF HYPERTENSION
- Cardiovascular effects of dipeptidyl peptidase-4 inhibitor in diabetic patients with and without established cardiovascular disease: a meta-analysis and systematic review
- (2016) Shishi Xu et al. POSTGRADUATE MEDICINE
- Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
- (2016) Ling Li et al. BMJ-British Medical Journal
- Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
- (2016) Ling Li et al. BMJ-British Medical Journal
- The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions
- (2016) Michael A Nauck et al. Lancet Diabetes & Endocrinology
- Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus
- (2016) Darren K. McGuire et al. JAMA Cardiology
- Kidney Disease End Points in a Pooled Analysis of Individual Patient–Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes
- (2015) Mark E. Cooper et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Dipeptidyl peptidase-4 inhibitors in progressive kidney disease
- (2015) Yuichi Makino et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Cardiovascular and non-cardiovascular safety of dipeptidyl peptidase-4 inhibition: a meta-analysis of randomized controlled cardiovascular outcome trials
- (2015) A. S. Abbas et al. DIABETES OBESITY & METABOLISM
- Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database
- (2015) Gian Paolo Fadini et al. EUROPEAN HEART JOURNAL
- Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in diabetic patients: A meta-analysis
- (2015) Gianluigi Savarese et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Hospitalisation for heart failure and mortality associated with dipeptidyl peptidase 4 (DPP-4) inhibitor use in an unselected population of subjects with type 2 diabetes: a nested case-control study
- (2015) C. B. Giorda et al. BMJ Open
- Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial
- (2014) Benjamin M. Scirica et al. CIRCULATION
- Brain natriuretic peptide
- (2014) Gnanadevan Mahadavan et al. CURRENT OPINION IN CARDIOLOGY
- The Effects of Dipeptidyl Peptidase-4 Inhibition on Microvascular Diabetes Complications
- (2014) Angelo Avogaro et al. DIABETES CARE
- Peptide YY: more than just an appetite regulator
- (2014) Shanta J. Persaud et al. DIABETOLOGIA
- Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
- (2014) Erin E. Mulvihill et al. ENDOCRINE REVIEWS
- Dipeptidyl Peptidase IV Inhibitors and Ischemic Myocardial Injury
- (2014) Alyssa H. Yoon et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- CXCR4 blockade induces atherosclerosis by affecting neutrophil function
- (2014) Ilze Bot et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Dipeptidyl peptidase-4 inhibitors and heart failure: A meta-analysis of randomized clinical trials
- (2014) M. Monami et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms
- (2014) Belén Picatoste et al. PLoS One
- Dipeptidyl‐Peptidase 4 Inhibition and the Vascular Effects of Glucagon‐like Peptide‐1 and Brain Natriuretic Peptide in the Human Forearm
- (2014) Jessica K. Devin et al. Journal of the American Heart Association
- Sitagliptin Use in Patients With Diabetes and Heart Failure
- (2014) Daniala L. Weir et al. JACC-Heart Failure
- Circulating Dipeptidyl Peptidase IV Activity Correlates With Cardiac Dysfunction in Human and Experimental Heart Failure
- (2013) Leonardo dos Santos et al. Circulation-Heart Failure
- GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects
- (2013) José C. Fernández-García et al. CLINICAL ENDOCRINOLOGY
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- A diseased bone marrow fuels atherosclerosis in diabetes
- (2012) Gian Paolo Fadini ATHEROSCLEROSIS
- Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy
- (2012) Gian Paolo Fadini et al. BASIC RESEARCH IN CARDIOLOGY
- Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans
- (2012) G. P. Fadini et al. DIABETES CARE
- Dipeptidyl Peptidase 4 Inhibition May Facilitate Healing of Chronic Foot Ulcers in Patients with Type 2 Diabetes
- (2012) Raffaele Marfella et al. Experimental Diabetes Research
- Diabetes impairs mobilization of stem cells for the treatment of cardiovascular disease
- (2012) Gian Paolo Fadini et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Renal and Cardiac Effects of DPP-4 Inhibitors from Preclinical Development to Clinical Research
- (2012) Berthold Hocher et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Reduced Brain Natriuretic Peptide Levels in Class III Obesity: The Role of Metabolic and Cardiovascular Factors
- (2012) Alline Beleigoli et al. Obesity Facts
- Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials
- (2011) Matteo Monami et al. CURRENT MEDICAL RESEARCH AND OPINION
- The increased dipeptidyl peptidase-4 activity is not counteracted by optimized glucose control in type 2 diabetes, but is lower in metformin-treated patients
- (2011) G. P. Fadini et al. DIABETES OBESITY & METABOLISM
- Diabetic Stem-Cell “Mobilopathy”
- (2011) John F. DiPersio NEW ENGLAND JOURNAL OF MEDICINE
- Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis
- (2011) Hans D. Theiss et al. Stem Cell Research
- Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice
- (2010) M. Sauve et al. DIABETES
- The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes: Possible role of stromal-derived factor-1
- (2010) G. P. Fadini et al. DIABETES CARE
- Time Course and Mechanisms of Circulating Progenitor Cell Reduction in the Natural History of Type 2 Diabetes
- (2010) G. P. Fadini et al. DIABETES CARE
- Glucagon-like peptide-1(9-36)amide metabolite inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice
- (2010) E. Tomas et al. DIABETES OBESITY & METABOLISM
- Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice
- (2010) M. Albiero et al. DIABETOLOGIA
- Dipeptidyl Peptidase IV Inhibition Alters the Hemodynamic Response to Angiotensin-Converting Enzyme Inhibition in Humans With the Metabolic Syndrome
- (2010) Edwin K. Jackson HYPERTENSION
- Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial) — Rationale, design and first interim analysis
- (2010) Hans D. Theiss et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
- (2009) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes
- (2009) Shrikanth H. Havale et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial Infarction
- (2009) Marc-Michael Zaruba et al. Cell Stem Cell
- The CXCL12 (SDF-1)/CXCR4 Axis Is Essential for the Development of Renal Vasculature
- (2009) Y. Takabatake et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways
- (2008) Kiwon Ban et al. CIRCULATION
- Decreased Vascular Repair and Neovascularization with Ageing: Mechanisms and Clinical Relevance with an Emphasis on Hypoxia- Inducible Factor-1
- (2008) Michel Hoenig et al. CURRENT MOLECULAR MEDICINE
- Sitagliptin Augments Sympathetic Enhancement of the Renovascular Effects of Angiotensin II in Genetic Hypertension
- (2008) Edwin K. Jackson et al. HYPERTENSION
- Protective effects of GLP-1 analogues exendin-4 and GLP-1(9–36) amide against ischemia–reperfusion injury in rat heart
- (2007) David P. Sonne et al. REGULATORY PEPTIDES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now